Description
VX-11e inhibits ERK2 and exhibits anticancer activity. VX-11e also displays some inhibitory activity against aurora kinase A (AurA), glycogen synthase kinase 3 (GSK-3), CDK2, FLT3, ROCK1, and JNK3.
VX-11e inhibits ERK2 and exhibits anticancer activity. VX-11e also displays some inhibitory activity against aurora kinase A (AurA), glycogen synthase kinase 3 (GSK-3), CDK2, FLT3, ROCK1, and JNK3.
Cas No. | 896720-20-0 |
---|---|
Purity | ≥98% |
Formula | C24H20Cl2FN5O2 |
Formula Wt. | 500.35 |
IUPAC Name | 4-[2-(2-chloro-4-fluoroanilino)-5-methylpyrimidin-4-yl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide |
Synonym | ERK 11e, TCS ERK 11e |
Solubility | DMSO 100 mg/mL (199.86 mM) Ethanol 16 mg/mL (31.97 mM) Water Insoluble |
Appearance | Off-white Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Aronov AM, Tang Q, Martinez-Botella G, et al. Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control. J Med Chem. 2009 Oct 22;52(20):6362-8. PMID: 19827834.
Kynurenine 3-hydroxylase inhibitor.
α-glucosidase inhibitor.
Inhibitor of PTEFb/CDK9.
Synthetic nitrile compound
p110β PI3K inhibitor.
EGFR, VEGFR inhibitor.
Xanthine derivative; adenosine antagonist, PDE ...
2’-Benzoylcarbonyl D-seco-Taxol is an impurit...
Imidazoline derivative; α1-adrenergic agonist,...
Fermentation impurity
PKC and PKD activator, carcinogen.
SIRT1/2 inhibitor, indirect p53 activator.
Dihydropyridine; L-type Ca2+ channel blocker.
Polyether Ca2+ ionophore.
VEGFR, PDGFR, c-Kit, RET inhibitor.
Neurotoxin, mutagen.
Alternaria mycotoxin which may be found in food...
Polyphenol found in Camilla sinensis; HIV integ...
Broad-spectrum antiviral activity against SARS-...
Triterpene saponin found in Panax.